Results for “ ”

Entry Author Date Location
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy 01/31/20 San Francisco
Arcutis Bio Raises $159M in Upsized IPO to Test Skin Disease Drugs 01/31/20 San Diego
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More 01/31/20 National
BIO Report: More Work Needed to Improve Diversity at Biotech Firms 01/30/20 National
Agenda and Speakers Announced for Xcelerating Life Sciences San Diego 01/29/20 National
Histogen, Timber Pharma Plan Reverse Mergers to Join Public Markets 01/28/20 San Diego
Third Time’s the Charm as Acceleron Drug Shows Early Promise in PAH 01/28/20 Boston
BioIntelliSense Debuts “Sticker” Sensor to Capture Patient Data Remotely 01/28/20 Boulder/Denver
Advanced Therapies Are Reshaping Biopharma R&D: KPMG Report 01/28/20 National
Life Sciences IPOs Target Collective Raise of More Than $600M This Week 01/27/20 National
Bio Roundup: Coronavirus Concerns, Sarepta’s CRL, Eye Drug OK’d & More 01/24/20 National
CEOs of Women’s Health Companies Fight to Open Investment Floodgates 01/22/20 San Diego
After Ending Cancer Drug Program, Halozyme Predicts Profits in 2020 01/21/20 San Diego
Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More 01/17/20 National
Event Announcement: Xcelerating Life Sciences San Diego 01/16/20 National
FDA Panel Votes Down Nektar Opioid Painkiller, Asks for More Data 01/14/20 National
Daré Bioscience Inks Deal With Bayer for Non-Hormonal Contraceptive 01/14/20 San Diego
NeoGenomics Nabs Human Longevity’s Oncology Division for $37M 01/13/20 National
Neurocrine, in Second Epilepsy Deal, Pairs With Swiss Biotech Idorsia 01/11/20 San Diego
Biotech Roundup: Drug Pricing Promises, Bone Disease Data, IPO Plans & More 01/10/20 National
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs 01/09/20 San Diego
Empirico Raises $17M, Inks 3-Year Antisense Collaboration with Ionis 01/09/20 San Diego
Mirati Adds Execs With Commercial Experience at Spark, Bristol-Myers 01/08/20 San Diego
Celgene-Seeded PharmAkea Sells Last Fibrotic Drug Candidate to Galecto 01/07/20 San Diego
BioIntervene Raises $30M to Move Nerve Pain Drug Into the Clinic 01/07/20 San Diego
Bio Roundup: FDA Approvals, Intrexon’s Shift, Melinta Bankruptcy & More 01/03/20 National
After Antitrust Challenges, Illumina and PacBio Throw in Towel on Merger 01/03/20 San Diego
Bio Roundup: Amarin’s Approval, FTC v. Illumina, a $120M Deal & More 12/20/19 National
Biogen Strikes Alzheimer’s Deal, Paying $45M for Ionis Tau Drug Rights 12/19/19 San Diego
FTC Challenges PacBio Acquisition, Says Illumina is a “Monopolist” 12/18/19 San Diego
Page 2 of 186 « previous page · next page »